While markers like 18F-fluorodeoxyglucose (FDG), tau tangles, and amyloid-β (Aβ) plaques are key in AD pathology, previous studies have shown that Aβ deposition has a weak correlation with cognition decline (Hedden et al., 2013). The gene discussed is MAPT; the disease is Alzheimer disease.